Analysts showing optimistic trends for Huazhu Group Limited(NASDAQ:HTHT): Viveve Medical, Inc.(NASDAQ:VIVE)

0
2

Huazhu Group Limited (HTHT) will report its next earnings on Mar 12 AMC. The company reported the earnings of $0.19/Share in the last quarter where the estimated EPS by analysts was $0.3/share. The difference between the expected and actual EPS was $-0.11/share, which represents an Earnings surprise of -36.7%.

Many analysts are providing their Estimated Earnings analysis for Huazhu Group Limited and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $0.2/share. These analysts have also projected a Low Estimate of $0.17/share and a High Estimate of $0.23/share.

In case of Revenue Estimates, 4 analysts have provided their consensus Average Revenue Estimates for Huazhu Group Limited as 413.01 Million. According to these analysts, the Low Revenue Estimate for Huazhu Group Limited is 407.07 Million and the High Revenue Estimate is 420.07 Million. The company had Year Ago Sales of 390.15 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for HTHT to be 17.7%. They are projecting Next Quarter growth of 140%. For the next 5 years, Huazhu Group Limited is expecting Growth of 30.05% per annum, whereas in the past 5 years the growth was -15.48% per annum.

Some buy side analysts are also providing their Analysis on Huazhu Group Limited, where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.92 and Average Volume (3 months) is 1.72 million. The company’s P/E (price to earnings) ratio is 111.78 and Forward P/E ratio of 38.62.

The company shows its Return on Assets (ROA) value of 1.9%. The Return on Equity (ROE) value stands at 10.9%. While it’s Return on Investment (ROI) value is 11.1%.

While looking at the Stock’s Performance, Huazhu Group Limited currently shows a Weekly Performance of 8.73%, where Monthly Performance is -3.14%, Quarterly performance is 0%, 6 Months performance is 21.23% and yearly performance percentage is 9.05%. Year to Date performance value (YTD perf) value is -7.66%. The Stock currently has a Weekly Volatility of 4.24% and Monthly Volatility of 4.58%.

Viveve Medical, Inc. (VIVE) will report its next earnings on Mar 12 AMC. The company reported the earnings of $-13.51/Share in the last quarter where the estimated EPS by analysts was $-16/share. The difference between the expected and actual EPS was $2.49/share, which represents an Earnings surprise of 15.6%.

Many analysts are providing their Estimated Earnings analysis for Viveve Medical, Inc. and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

In case of Revenue Estimates, 1 analysts have provided their consensus Average Revenue Estimates for Viveve Medical, Inc. as 1.12 Million. According to these analysts, the Low Revenue Estimate for Viveve Medical, Inc. is 1.12 Million and the High Revenue Estimate is 1.12 Million. The company had Year Ago Sales of 4.47 Million.

The Relative Volume of the company is 2.14 and Average Volume (3 months) is 1.53 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -125.5%. The Return on Equity (ROE) value stands at 585.8%. While it’s Return on Investment (ROI) value is -127%.

While looking at the Stock’s Performance, Viveve Medical, Inc. currently shows a Weekly Performance of 27%, where Monthly Performance is 38.04%, Quarterly performance is -63.92%, 6 Months performance is -90.23% and yearly performance percentage is -98.78%. Year to Date performance value (YTD perf) value is 0.79%. The Stock currently has a Weekly Volatility of 13.83% and Monthly Volatility of 11.21%.

SHARE